vimarsana.com
Home
Live Updates
Theratechnologies Announces All U.S. Oncology Clinical Sites
Theratechnologies Announces All U.S. Oncology Clinical Sites
Theratechnologies Announces All U.S. Oncology Clinical Sites Now Enrolling for Phase 1 Trial of Sudocetaxel Zendusortide
MONTREAL, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmac...
Related Keywords
Canada ,
Montreal ,
Quebec ,
Julie Schneiderman ,
Philippe Dubuc ,
Sudocetaxel Zendusortide ,
Communications Corporate Affairs ,
Theratechnologies Inc ,
Company Phase ,
Forward Looking Statements ,
Looking Statements ,
Annual Information Form ,
Vice President ,
Chief Financial Officer ,